Skip to main content

Table 2 Baseline and clinical characteristics of subjects with bronchiectasis, with and without cardiovascular disease

From: Clinical impact of cardiovascular disease on patients with bronchiectasis

ParameterBronchiectasis
(n = 404)
Bronchiectasis with cardiovascular disease (n = 199)P-value
Age, years61.97 ± 11.1765.35 ± 9.750.107
Sex male: female n191:21380:1190.1
BMI, kg/m223.81 ± 3.4523.51 ± 3.220.591
Smoking17.6%16.6%0.762
Previous pneumonia38.9%33.2%0.173
Previous tuberculosis12.4%20.6%0.008
Previous anaphylactic rhinitis2.2%1.5%0.552
Presenting symptoms
 Cough70.3%73.4%0.433
 Wheezing51.2%65.3%0.001
 Hemoptysis44.6%34.7%0.02
P.aeruginosa isolation22.8%30.2%0.063
Type
 Cylindrical28.2%22.6%0.142
 Cystic35.1%40.7%0.184
 Mixed36.6%36.7%0.99
Location
 Unilateral25.0%26.1% 
 Bilateral75.0%73.9%0.764
Extent
 Affected lobes n3.21 ± 1.473.12 ± 1.430.465
 Affected segments n8.50 ± 5.158.71 ± 4.700.011
  1. Data are presented as the mean ± SD or %, unless otherwise stated. BMI body mass index. Data presented in bold type are statistically significant